Mobisyl Cream
NDC Package 0225-0360-35
Package Information
Mobisyl (trolamine salicylate) cream is useFor temporarily relief of minor aches and pains of muscles and joints associated with arthritis, simple backache, lumbago, neuralgia, strains, bruises, and sprains. This formulation utilizes a cream delivery system. Marketed by Bf Ascher And Co Inc, this product is identified by NDC 0225-0360 and is authorized under FDA application 505G(a)(3).
Identification & Billing
- RxCUI: 1101836 - Mobisyl 10 % Topical Cream
- RxCUI: 1101836 - trolamine salicylate 100 MG/ML Topical Cream [Mobisyl]
- RxCUI: 1101836 - Mobisyl 100 MG/ML Topical Cream
- RxCUI: 313518 - trolamine salicylate 10 % Topical Cream
- RxCUI: 313518 - trolamine salicylate 100 MG/ML Topical Cream
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0225 - Bf Ascher And Co Inc
- 0225-0360 - Mobisyl
- 0225-0360-35 - 226.8 g in 1 JAR
- 0225-0360 - Mobisyl
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0225-0360). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0225-0360-35 identifies a specific commercial package of 226.8 g in 1 jar of Mobisyl, a human over the counter drug labeled by Bf Ascher And Co Inc. This cream is formulated for topical use and contains trolamine salicylate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bf Ascher And Co Inc on September 19, 2014. The current certification is valid through December 31, 2026.
How is this Bf Ascher And Co Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00225036035. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 226.8 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.